Literature DB >> 20940194

Bevacizumab and everolimus in renal cancer: a rational way forward.

Walter M Stadler, George Phillips, Daniel J George, Susan Halabi, Eric Small.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940194     DOI: 10.1200/JCO.2010.30.7934

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Design issues in randomized phase II/III trials.

Authors:  Edward L Korn; Boris Freidlin; Jeffrey S Abrams; Susan Halabi
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

2.  Forty-nine-month survival in a metastatic renal cell carcinoma patient across six lines of targeted therapy.

Authors:  T Raja
Journal:  Ecancermedicalscience       Date:  2014-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.